Estée Lauder
No proof required
Up to $5,000
Claims opening soon
M
Mylan Pharmaceuticals
Mylan agreed to a $73.5 million settlement over claims it conspired to suppress generic EpiPens and extend its monopoly.
ClosedUnited States-wideClaim status: Closed on May 29, 2025Payout: TBDNo longer claimable
About this settlement
Claims relate to alleged illegal suppression of generic EpiPens to extend Mylan's monopoly on the product.
This settlement resolves allegations that Mylan conspired with other companies to block generic EpiPens, maintaining a monopoly and inflating prices. Eligible purchasers of EpiPen or generic EpiPen products may file claims for compensation.
Who qualifies
- Entities that purchased EpiPen or generic EpiPen products directly from Mylan or Teva.
- Purchases made between March 13, 2014 and February 6, 2025.
TBD
Claim status: Closed on May 29, 2025
Audible
No proof required
Compensation pending
Claims opening soon
Government of Canada
Proof required
Up to $200,000
645 days left
Meta (Facebook)
No proof required
Up to $90
Claims opening soon
Ticketmaster
No proof required
Compensation pending
Claims opening soon
Apple
No proof required
Up to $100
Claims opening soon